Dexcom (DXCM) FCF Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Dexcom (DXCM) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 177.98 Bn | 7.27 Bn | 884.00 |
| 2 | Intuitive Surgical | 124.59 Bn | 119.38 Bn | 1.96 Bn | 503.00 |
| 3 | Medtronic | 118.07 Bn | 109.26 Bn | 6.34 Bn | 646.00 |
| 4 | Stryker | 106.00 Bn | 102.52 Bn | 4.50 Bn | 534.00 |
| 5 | Boston Scientific | 66.53 Bn | 65.99 Bn | 3.85 Bn | 919.00 |
| 6 | Edwards Lifesciences | 49.53 Bn | 45.27 Bn | 1.35 Bn | 3,472.00 |
| 7 | Alcon | 33.90 Bn | 32.44 Bn | 1.68 Bn | 353.00 |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | -97.00 |
| 9 | Steris | 21.06 Bn | 20.58 Bn | 684.20 Mn | 60.00 |
| 10 | Zimmer Biomet Holdings | 18.31 Bn | 17.90 Bn | 1.54 Bn | 468.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -97.00 |
| Mar 31, 2026 | 2,679.00 |
| Dec 31, 2025 | 679.00 |
| Sep 30, 2025 | 2,387.00 |
| Jun 30, 2025 | 638.00 |
| Mar 31, 2025 | 1,421.00 |
| Dec 31, 2024 | 1,221.00 |
| Sep 30, 2024 | -1,253.00 |
| Jun 30, 2024 | 2,789.00 |
| Mar 31, 2024 | 3,077.00 |
| Dec 31, 2023 | -1,181.00 |
| Sep 30, 2023 | 244.00 |
| Jun 30, 2023 | -616.00 |
| Mar 31, 2023 | 1,861.00 |
| Dec 31, 2022 | -1,306.00 |
| Sep 30, 2022 | 1,273.00 |
| Jun 30, 2022 | 645.00 |
| Mar 31, 2022 | 494.00 |
| Dec 31, 2021 | -107.00 |
| Sep 30, 2021 | 904.00 |